Suchergebnisse - "Hou, Zhiguo"

PubPharm (9)

1

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC : a drug-drug interaction study

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Ma, Y. | Chen, Q. | Zhang, Y. | +11

2

Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer : protocol of a multicenter, open-label, randomized phase 2 trial

enthalten in: Translational cancer research | 2023

von Hou, Z. | Lan, C. | Huang, X. | +2

3

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Ma, Y. | Chen, Q. | Zhang, Y. | +11

4

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Ma, Y. | Chen, Q. | Zhang, Y. | +11

5

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Ma, Y. | Chen, Q. | Zhang, Y. | +11

6

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD) : a prospective, single-arm, multicenter, phase IV study

enthalten in: BMC medicine | 2023

von Li, J. | Qin, S. | Wen, L. | +32

7

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

enthalten in: BMC medicine | 2023

von Li, J. | Qin, S. | Wen, L. | +32

8

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

enthalten in: BMC medicine | 2023

von Li, J. | Qin, S. | Wen, L. | +32

9

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC : The Phase III ACTIVE Study (CTONG1706)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Zhao, H. | Yao, W. | Min, X. | +23

CommentIn: J Thorac Oncol. 2021 Sep;16(9):1426-1428. - PMID 34425993

1
[1]